Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2f322885e368eae5d74722bc28daf653 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ebaaf03a714aad5977b9914508974b4e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f87932bfccb68ebc36ee124c6d3964a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_951917139791ec3a768eac3bb56ec280 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75f8d6855f3b0bff4a76275ceba5d5ff |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N15-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N15-06 |
filingDate |
2013-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2015-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d4d7d842f8d9ecfe898de1c3e13dd92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd966e4627e29d51df16c084105364a5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddf7e88abe04e9fe29cef38631e155ee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75b67cebd773fcf0977bf4e57032affe |
publicationDate |
2015-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9057675-B2 |
titleOfInvention |
Methods of formulating and designing liquid drug suspensions containing ion exchange resin particles |
abstract |
The invention relates to the formulation and quality control of liquid drug suspensions. In particular, the invention relates to methods of formulating liquid suspensions comprising drug-containing resin particles. The invention also relates to methods of confirming the acceptability of drug-containing resin particles for use in formulating liquid drug suspensions. The invention further relates to methods of formulating liquid suspensions in which drug-containing resin particles, the liquid suspension, or both are modified to achieve a desired in vitro dissolution profile. The invention also relates to a novel dissolution method and methods of predicting in vivo bioequivalence based on in vitro dissolution methods. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9545399-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9675703-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9675704-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11103494-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11103495-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11590228-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11590081-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10857143-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11633389-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10086087-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10507203-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9844544-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9844545-B2 |
priorityDate |
2010-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |